APA

Guleria A. S., Yang J. C., Topalian S. L., Weber J. S., Parkinson D. R., MacFarlane M. P., White R. L., Steinberg S. M., White D. E. & Einhorn J. H. (19950112). Renal dysfunction associated with the administration of high-dose interleukin-2 in 199 consecutive patients with metastatic melanoma or renal carcinoma. : Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Chicago

Guleria A S, Yang J C, Topalian S L, Weber J S, Parkinson D R, MacFarlane M P, White R L, Steinberg S M, White D E and Einhorn J H. 19950112. Renal dysfunction associated with the administration of high-dose interleukin-2 in 199 consecutive patients with metastatic melanoma or renal carcinoma. : Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Harvard

Guleria A. S., Yang J. C., Topalian S. L., Weber J. S., Parkinson D. R., MacFarlane M. P., White R. L., Steinberg S. M., White D. E. and Einhorn J. H. (19950112). Renal dysfunction associated with the administration of high-dose interleukin-2 in 199 consecutive patients with metastatic melanoma or renal carcinoma. : Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

MLA

Guleria A S, Yang J C, Topalian S L, Weber J S, Parkinson D R, MacFarlane M P, White R L, Steinberg S M, White D E and Einhorn J H. Renal dysfunction associated with the administration of high-dose interleukin-2 in 199 consecutive patients with metastatic melanoma or renal carcinoma. : Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 19950112.